Comprehensive coverage for genome-wide DNA methylation studies

Quantitatively interrogate methylation sites across the genome at single-nucleotide resolution

Methylation Array Analysis

DNA methylation plays an important and dynamic role in regulating gene expression. It allows cells to acquire and maintain a specialized state, suppresses the expression of viral and nonhost DNA elements, and facilitates response to environmental stimuli. Aberrant DNA methylation (hyper- or hypomethylation) and its impact on gene expression have been implicated in many normal and aberrant biological processes.

Infinium Methylation Arrays

Our Infinium MethylationEPIC and Mouse Methylation BeadChips allow you to interrogate 850,000 or 285,000 markers, respectively, across the genome at single-nucleotide resolution.

Human MethylationEPIC BeadChip

Powered by the Infinium assay, the MethylationEPIC BeadChip is ideal for epigenome-wide association studies (EWAS), tumor profiling, and various cell biology experiments. It offers comprehensive, expeert-selected coverage, including 99% of RefSeq genes, 95% of CpG islands, high coverage of enhancer regions, and other content categories. With > 90% of the original content from the Infinium HumanMethylation450K covered, the MethylationEPIC kit supports the next generation of epigenetics research.

Mouse Methylation BeadChip

Also leveraging the Infinium assay, the Mouse Methylation BeadChip can be used in EWAS and other experiments probing the methylome in healthy and diseased tissues. Much like the MethylationEPIC BeadChip, the Mouse Methylation BeadChip offers genome-wide coverage, with probes targeted to CpG islands, enhancer regions, transcription start sites, and other important regions of the methylome.

Our methylation arrays combine comprehensive coverage and high-throughput capabilities. Advantages include:

  • Comprehensive genome-wide coverage
    • CpG islands
    • Non-CpG and differentially methylated sites
    • Enhancers
    • Open chromatin
    • Transcription factor binding sites
    • miRNA promoter regions
  • Assay reproducibility
    • > 98% reproducibility between technical replicates for all Infinium methylation arrays
    • 98% for the same samples on the legacy HumanMethylation450K array vs. the MethylationEPIC array
    • MethylationEPIC contains > 90% of the HumanMethylation450K content
  • User-friendly, streamlined workflow
  • MethylationEPIC has been validated with FFPE samples
iScan

Our methylation arrays follow a user-friendly, streamlined workflow, enabling processing of up to 96 samples simultaneously from low sample input (as little as 250 ng).

Offering quantitative measurement at the single-CpG-site level, these methylation microarrays offer powerful resolution for understanding epigenetic changes.

Click on the below to view products for each workflow step.

MethylationEPIC BeadChip

Robust methylation profiling microarray with extensive coverage of CpG islands, genes, and enhancers. Use for epigenome-wide association studies and other experiments.

Infinium Mouse Methylation BeadChip

Features > 285k markers across the methylome for high resolution epigenetic analyses of diverse murine strains.

iScan System

Supports high-throughput BeadChip processing, scanning hundreds to thousands of samples quickly and accurately.

NextSeq 550 System

Perform next-generation sequencing and methylation array scanning all on one platform.

GenomeStudio Software and Methylation Module

Effortless differential methylation analysis and display of chromosomal coordinates, % GC, location in CpG island, and methylation ß values.

Explore a variety of methods used to detect cytosine modifications, including methylation arrays, and learn more about the impact of cytosine methylation.

Read Guide
Field Guide to Methylation Methods
The Epigenetic Patterns of Exercise

Dr. Sundberg at the Karolinska Institute uses methylation arrays and RNA-Seq to reveal exercise-related epigenetic changes.

Read Interview
Scouring The Epigenome For The Origins Of Dementia and Mental Illness

Dr. Mill at King’s College London uses methylation arrays to identify epigenetic changes that contribute to neurodegenerative disorders.

Read Interview
Epigenetics Studies Uncover Obesity-Driven Methylation Signatures

Dr. Samani at University of Leicester uses methylation arrays to identify cell signaling disruption linked with high BMI.

Read Interview
Complex Disease Studies
Methylation Profiling for Complex Disease Studies

Methylation array studies enable researchers to understand the functional mechanisms at work in complex disease. Illumina offers complementary solutions for researchers studying these disorders. Learn more about complex disease research.

Epigenetics and Cancer
Cancer Epigenetics

Illumina array and sequencing solutions are ideal for detecting altered methylation patterns and epigenetic changes that provide insight into tumorigenic pathways and cancer progression. Learn more about cancer epigenetics.

Comprehensive molecular characterization of urothelial bladder carcinoma.

Nature 507 315-22 2014

Read Abstract

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy.

Nature 506 445-50 2014

Read Abstract

Whole-genome sequence-based analysis of thyroid function.

Nat Commun 6 5681 2015

Read Abstract
Interested in receiving newsletters, case studies, and information on genomic analysis techniques? Enter your email address.
Methylation Sequencing
Methylation Sequencing

Methylation sequencing approaches offer higher density and flexibility in assessing epigenome changes.

Learn More
FastTrack Microarray Services
FastTrack Microarray Services

Illumina experts provide methylation array and genotyping services.

Learn More
Methylation Array Data Analysis
Methylation Array Data Analysis Tips from Experts

Experts describe their approaches to analyzing Illumina methylation array data.

Learn More
Epigenome-Wide Association Studies
Epigenome-Wide Association Studies

Epigenetic changes in newborns linked with maternal smoking during pregnancy.

Access PDF